Enhancing treatment options of triple-negative breast cancer
New research trials the use of image-guided co-drug delivery to target difficult tumour types. Approximately 15-20% of breast cancer cases are described as triple-negative, meaning they do not have receptors for the hormones estrogen or progesterone, and do not...
Light-emitting tattoo engineered for the first time
Scientists at the LCN and the IIT –Istituto Italiano di Tecnologia (Italian Institute of Technology) have created a temporary tattoo with light-emitting technology used in TV and smartphone screens, paving the way for a new type of “smart tattoo” with a range of...
Using nanomaterials and biosensors to diagnose
LCN Professor Molly Stevens and her research group were interviewed for the Winter edition of Imperial Magazine. The article explores the group’s research into the fast and accurate diagnosis of diseases like HIV and Malaria. To read the full article please...